HealthStream, Inc. (HSTM) — Fair Value Analysis
Base-case fair value (P50): $24.98 · Current price: $22.70 · Verdict: Fairly Valued
The Verdict on HSTM
HEALTHSTREAM INC (HSTM) is currently assessed as Fairly Valued based on our latest Monte Carlo simulations. At its current trading price of $22.70, HSTM presents an implied +10.0% upside to our median fair value estimate of $24.98. This indicates that, while not significantly undervalued, the stock shows a modest positive spread compared to its intrinsic value. Our rigorous simulations, exploring thousands of future scenarios, suggest that HSTM's current market price aligns reasonably well with its fundamental outlook, reinforcing the "Fairly Valued" verdict. Investors should note this +10.0% represents the central tendency of potential outcomes from our probabilistic modeling.
How HSTM stacks up against peers
HSTM's operational and financial health is currently rated as average when compared to its sector peers. This average quality tier suggests that while HEALTHSTREAM INC maintains a stable position, it does not currently exhibit superior operational efficiency or financial robustness that would warrant a significant premium. The average quality is factored into our fair value calculations, influencing the median fair value of $24.98. The Monte Carlo simulations incorporate this competitive context, ensuring that the valuation reflects HSTM's standing relative to others in its industry. This perspective is crucial when evaluating the current price of $22.70 against its intrinsic worth.
What this means for investors
For investors considering HSTM, the "Fairly Valued" verdict, coupled with a +10.0% projected upside to our $24.98 fair value, points to a stock that is largely priced efficiently. While there's a slight premium to be captured, significant undervaluation is not present at $22.70. Our Monte Carlo simulations, which form the core of the FairCurve methodology, consider a wide range of future possibilities, providing a robust estimate. Exploring the full distribution of these simulations, including potential bear and bull cases, offers a more complete picture of HSTM's risk-reward profile. Sign up for a free FairCurve account to see the full bear/bull distribution and track HSTM's fair value as new fundamentals are released.
Frequently Asked Questions
Is HSTM overvalued or undervalued right now?
Based on our Monte Carlo simulations, HSTM is currently assessed as fairly valued. Its current price of $22.70 sits below our median fair value estimate of $24.98, implying a +10.0% potential upside.
What is the bear case and bull case for HSTM?
The full Monte Carlo distribution, including specific bear (P10) and bull (P90) target prices, along with the probability of achieving upside scenarios, is available to subscribers. You can unlock these details with a free FairCurve account.
How does FairCurve calculate HSTM's fair value?
FairCurve employs Monte Carlo simulations that model thousands of forward scenarios for HSTM, considering various inputs and market dynamics to derive a probabilistic fair value distribution.
How can I track HSTM's fair value as it changes?
You can add HSTM to your free FairCurve watchlist to receive daily fair-value updates and immediate re-valuation alerts whenever new financial data, like earnings reports, are released.